IRIS
Bouba, Yagai
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 790
NA - Nord America 467
SA - Sud America 270
EU - Europa 152
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 430
SG - Singapore 317
BR - Brasile 202
CN - Cina 140
HK - Hong Kong 107
IT - Italia 88
VN - Vietnam 58
CD - Congo 38
BD - Bangladesh 28
IN - India 25
AR - Argentina 24
MX - Messico 24
CM - Camerun 23
ID - Indonesia 14
IQ - Iraq 14
FI - Finlandia 12
PK - Pakistan 11
TR - Turchia 11
CO - Colombia 10
MY - Malesia 10
EC - Ecuador 9
ZA - Sudafrica 9
MA - Marocco 8
PY - Paraguay 8
SA - Arabia Saudita 8
UA - Ucraina 8
FR - Francia 7
UZ - Uzbekistan 7
TN - Tunisia 6
VE - Venezuela 6
CA - Canada 5
GB - Regno Unito 5
PH - Filippine 5
DE - Germania 4
EG - Egitto 4
ES - Italia 4
NG - Nigeria 4
NP - Nepal 4
RU - Federazione Russa 4
UY - Uruguay 4
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
OM - Oman 3
PL - Polonia 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MN - Mongolia 2
MW - Malawi 2
MZ - Mozambico 2
PE - Perù 2
AU - Australia 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NE - Niger 1
NL - Olanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TD - Ciad 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 1.791
Salva come PNG Salva come JPEG
Città #
San Jose 269
Singapore 176
Hong Kong 106
Beijing 80
Ashburn 61
Rome 57
Kinshasa 38
Ho Chi Minh City 28
New York 19
Hanoi 16
Mexico City 16
São Paulo 15
Santa Clara 14
Yaoundé 13
Turku 12
Milan 9
Baghdad 7
Brasília 7
Belo Horizonte 6
Goiânia 6
Rio de Janeiro 6
Tashkent 6
Asunción 5
Dhaka 5
Lahore 5
Porto Alegre 5
Campinas 4
Jakarta 4
Kuala Lumpur 4
Los Angeles 4
Riyadh 4
Abuja 3
Agadir 3
Cairo 3
Curitiba 3
Dietikon 3
Fortaleza 3
Haiphong 3
Istanbul 3
Jaboatão dos Guararapes 3
Kingston 3
Medellín 3
Montevideo 3
Muscat 3
Quito 3
Sete Lagoas 3
Americana 2
Antakya 2
Baku 2
Bari 2
Betim 2
Blantyre 2
Buenos Aires 2
Buffalo 2
Cachoeiro de Itapemirim 2
Camaçari 2
Caxias do Sul 2
Chennai 2
Dallas 2
Dammam 2
Durban 2
Franca 2
Genoa 2
Guayaquil 2
Hangzhou 2
Jequié 2
Johannesburg 2
Joinville 2
Kolkata 2
Lima 2
Luziânia 2
Magetan 2
Maputo 2
Mirassol 2
Mérida 2
Nairobi 2
Najaf 2
Ninh Bình 2
Petaling Jaya 2
Recife 2
Salvador 2
San José 2
Santo André 2
Santo Antônio da Patrulha 2
Sarandi 2
Senhor do Bonfim 2
Serra 2
The Bronx 2
Tunis 2
Ulan Bator 2
Vitória de Santo Antão 2
Volta Redonda 2
Vĩnh Tường 2
Abilene 1
Acacías 1
Ahmedabad 1
Ajman 1
Almaty 1
Am Timan 1
Ambato 1
Totale 1.153
Salva come PNG Salva come JPEG
Nome #
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 70
Determinants of Immunovirological Response among Children and Adolescents Living with HIV-1 in the Central Region of Cameroon 65
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 51
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 48
Evaluating the effectiveness of oral HIV self testing according to distribution models in Cameroon 47
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 47
HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries 47
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 46
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 45
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 42
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 41
Anti-toxoplasmic immunoglobulin G quantitation correlates with immunovirological parameters of HIV-infected cameroonians 40
The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: a Cross-Country Analysis 40
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 40
High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness 38
HIV MDR is still a relevant issue despite its dramatic drop over the years 38
The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies 38
Usability of three finger-stick whole blood HIV self-testing kits among men who have sex with men and female sex workers in Yaounde and Douala, Cameroon 37
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 36
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis 36
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 36
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure 35
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: Adolescents at high risk of virological failure in the era of "test and treat" 35
Human immunodeficiency virus is a driven factor of human papilloma virus among women: Evidence from a cross-sectional analysis in Yaoundé, Cameroon 34
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study 33
Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis 33
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics 32
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model 32
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol 32
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches 32
HIV-1 drug resistance in children and implications for pediatric treatment strategies: A systematic review and meta-analysis 32
The 2019 cameroon university games: Prevention strategies for musculoskeletal injuries 31
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocol 30
Covid-19 pandemic related research in africa: Bibliometric analysis of scholarly output, collaborations and scientific leadership 30
Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: A snapshot from the City of Yaoundé 30
COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon 30
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness 29
COVID-19 considerations and strategy for a safe return to international football competitions: an African perspective 29
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 28
Challenges faced by the HIV testing system in low- and middle-income countries 28
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis 28
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries 28
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon 28
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries 28
Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population 28
High concordance in SARS-CoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon 27
Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic 27
Predictors of Virological Failure among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 26
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings 25
Achieving the Global Agenda toward HIV Cure Calls for Establishing a Research-for-Cure Academy in West and Central Africa 25
Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé Cameroon: a crosssectional and analytical study 24
Physical Activity for Health Promotion and Disease Prevention in Africa and Cameroon: A Call to Action 22
Effectiveness of community-based peer facilitated psychological and social support interventions on improving mental health in Cameroonian adolescents with perinatal HIV: the IAS-CIPHER-2021/1214-ATE SMAVI controlled randomized trial (November 2021-May 2023) 18
Totale 1.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.368
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025496 9 0 46 14 5 3 86 60 31 12 109 121
2025/20261.361 76 9 134 100 127 99 177 67 291 199 82 0
Totale 1.857